Home
 /
Papers
 /
Microbiology
 /
An Anaerobic Pathogen Rewires Host Metabolism to Fuel Oxidative Growth in the Inflamed Gut
Preprint
Open access
V1
Top 1% · Validated by QED

An Anaerobic Pathogen Rewires Host Metabolism to Fuel Oxidative Growth in the Inflamed Gut

Luisella Spiga, Ryan T. Fansler, Alexandra Grote +24 more
May 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.05.31.657111
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Microbiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing that a canonical obligate anaerobe reprograms host epithelial metabolism to fuel its own oxidative respiration, this work overturns established microbial dogma and opens host-directed metabolic therapies for enteric infection and colorectal cancer.

QED claims analysis

Summary

Enterotoxigenic Bacteroides fragilis (ETBF) uses its virulence factor BFT to reprogram colonic epithelial metabolism from oxidative phosphorylation to glycolysis while simultaneously depleting immunomodulatory bile acids through manipulation of the host recycling pathway, thereby creating an oxygen- and lactate-rich inflammatory niche that ETBF exploits through an unexpected oxidative respiratory metabolism to establish colonization and promote tumorigenesis in the inflamed gut.

See full analysis
Main Claim 1 –

BFT Is Required for ETBF Gut Colonization and Pathogenesis

Main Claim 2 –

ETBF Uses Oxygen Respiration-Driven Oxidative Metabolism for Colonization

Supporting evidence

  • ETBF Expresses TCA Cycle and Respiratory Genes In Vivo
  • Oxygen and Lactate Synergize to Boost ETBF Oxidative Growth
  • Lactate Oxidation and Oxidative TCA Genes Drive ETBF Virulence
  • ETBF Oxidative Metabolism Promotes Tumorigenesis in ApcMin Mice
Main Claim 3 –

BFT Shifts Colonocytes from Oxidative Phosphorylation to Glycolysis

Supporting evidence

  • BFT-Induced Reprogramming Elevates Luminal Oxygen and Lactate
  • Tributyrin Restores Colonocyte Oxidation and Reduces ETBF Infection
  • BFT Increases Permeability via E-Cadherin Cleavage, Enhancing Oxygen Diffusion
  • BFT-Driven Crypt Hyperplasia Expands Glycolytic Colonocytes and Oxygenates Lumen
Main Claim 4 –

BFT Depletes Intestinal Bile Acids to Promote Pathogenesis

Supporting evidence

  • Bile Acid Depletion Enhances IL-17 Production by Intestinal Immune Cells
  • Bile Acids Reduce ETBF Disease by Restoring Epithelial Oxidative Metabolism
  • BFT Upregulates Host Bile Acid Recycling to Deplete Bile Acids
  • Maralixibat Inhibition of Bile Acid Recycling Reduces ETBF Pathogenesis

Abstract

To colonize their host and cause disease, enteric pathogens must deploy their virulence factors to establish distinct nutrient niches. How obligate anaerobic pathogens construct nutrient niches in the densely populated large intestine remains poorly understood. Enterotoxigenic Bacteroides fragilis (ETBF) is considered an obligate anaerobic bacterium and has been implicated in inflammation-associated diseases, including colitis and colorectal cancer. Here we show that ETBF uses its virulence factor, Bacteroides fragilis toxin, to reprogram colonic epithelial cell metabolism to colonize the inflamed gut. Bacteroides fragilis toxin activates colonic epithelial signaling and hijacks the host bile acid recycling pathway, inducing a metabolic shift in the epithelium from oxidative phosphorylation to glycolysis. This shift increases local concentrations of lactate and oxygen, nutrients that support an oxidative metabolism in ETBF. These findings reveal an unexpected strategy by which a pathogenic organism, previously considered to be an obligate anaerobic bacterium, generates and exploits an oxidative niche in the inflamed gut.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?